Examination of the Effects of Dual Task Exercise Training Combined With Action Observation Therapy in Children With Spastic Hemiplegic Cerebral Palsy

November 8, 2026 updated by: Günseli Usgu, Hasan Kalyoncu University

Examination of the Effects of Dual Task Exercise Training Combined With Action Observation Therapy in Children With Spastic Hemiplegic Cerebral Palsy in the Context of the International Classification of Functioning, Disability, and Health

Cerebral palsy (CP) is one of the most common neurodevelopmental disorders worldwide. Although the primary brain lesion is non-progressive, the severity of functional limitations and disability may increase over time due to impairments in muscle tone, balance, postural control, and movement. Furthermore, these impairments may restrict individuals' activity levels and participation in daily life. Various rehabilitation approaches have been described in the literature for individuals with cerebral palsy. Among these, Action Observation Therapy (AOT), which is based on the principles of neuroplasticity and motor learning, is an approach used in neurological rehabilitation. This method involves observing a movement before performing it and has been investigated for improving upper extremity function in individuals with hemiplegia, Parkinson's disease, and cerebral palsy. Dual-task performance refers to the simultaneous execution of a primary task and a secondary task. Performance during dual-task activities may be influenced by several factors, including the nature and difficulty of the tasks, instructions regarding task prioritization, and individual characteristics such as age, cognitive and motor abilities, attentional capacity, and fear of falling. Although studies investigating the use of Action Observation Therapy to improve trunk, upper extremity, and lower extremity functions in children with cerebral palsy are limited, the literature highlights the need to investigate dual-task training in this population. Therefore, this study aims to investigate the effects of dual-task training combined with Action Observation Therapy on body structures and functions, activity, and participation in children diagnosed with hemiplegic cerebral palsy. The findings are expected to contribute to the existing literature and provide further evidence regarding the potential benefits of this combined rehabilitation approach.

Study Overview

Detailed Description

Cerebral palsy (CP) is defined as a permanent but non-progressive neurodevelopmental disorder resulting from an injury to or abnormality in the developing fetal or infant brain, leading to activity limitations and impairments in movement development and postural control. Although CP is primarily characterized by motor impairments, it is frequently accompanied by sensory, perceptual, cognitive, and communication impairments, behavioral difficulties, and epilepsy. Hemiplegic CP is a clinical subtype in which the upper and lower extremities on the same side of the body are affected, with the upper extremity generally being more severely affected than the lower extremity.In addition to motor impairments, children with CP may experience difficulties in attentional processes, including divided attention and sustained attention, as well as in other executive functions. Spasticity, musculoskeletal impairments, deficits in motor control, and sensory-perceptual impairments, together with limitations in attention and executive functions, may adversely affect dual-task performance. Due to impairments in both cognitive and motor functions, performing cognitive and motor tasks simultaneously may pose additional challenges for children with CP. Consequently, these difficulties may interfere with the performance of daily activities requiring dual-task processing, thereby negatively affecting functional performance and levels of independence. Functional impairments affecting the extremities of individuals with CP may lead to difficulties in performing activities of daily living and reduced levels of independence. Furthermore, these impairments may restrict children's activity and participation. Various rehabilitation approaches are used in children with hemiplegic CP to improve trunk and extremity function, enhance functional performance, and reduce activity limitations. In particular, neurorehabilitation approaches based on the principles of neuroplasticity and motor learning play an important role in the rehabilitation of these children. Action Observation Therapy (AOT) is a rehabilitation approach that aims to facilitate motor learning and promote neuroplasticity. AOT is based on the principle of activating the motor system through the observation of movements and is associated with the mirror neuron system. Various studies have investigated the effectiveness of this approach. However, most existing studies have focused on adults following stroke or on improving upper extremity function in individuals with CP. These studies have reported beneficial effects of AOT on upper extremity function. In contrast, studies focusing on lower extremity and trunk rehabilitation in children with CP remain limited. The literature has demonstrated the presence of motor and cognitive impairments in children with CP, highlighting the need for further research targeting these domains. Therefore, the present study was designed to investigate the effects of dual-task training combined with AOT on body structures and functions, activity, and participation in children with hemiplegic CP.

Study Type

Interventional

Enrollment (Estimated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gaziantep, Turkey (Türkiye)
        • Hasan Kalyoncu University Department of Physical Therapy and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 15 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Children aged 7-15 years Diagnosed with hemiplegic cerebral palsy (CP),
  • Classified at level 1 or 2 according to the Gross Motor Function Classification System (GMFCS),
  • Classified at level 1, 2, or 3 according to the Eating and Drinking Ability Classification System (EDACS),
  • Classified at level 1 or 2 according to the Communication Function Classification System (CFCS),

Exclusion Criteria:

  • Presence of any neurological (except for epilepsy controlled with medication), orthopedic, or psychiatric diagnosis in addition to CP,
  • Having vision (excluding refractive errors) or hearing impairments,
  • Having undergone any surgical intervention (trunk, lower extremity, or upper extremity) or received Botox injections within the last 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Study group

Action Observation Treatment and Dual Task

Participants in the study group will receive 20 minutes of conventional physiotherapy, including stretching and strengthening exercises. This will be followed by 20 minutes of action observation therapy, during which participants will perform the specified activities using a dual-task approach, simultaneously engaging in cognitive and motor tasks. The intervention will be implemented over an 8-week period, consisting of two sessions per week administered by a physiotherapist and one home-based session per week conducted by the family.

Experimental: Control group

Action Observation Treatment

Participants in the control group will receive 20 minutes of conventional physiotherapy, including stretching and strengthening exercises. This will be followed by 20 minutes of action observation therapy, during which participants will perform the designated activities without the addition of a dual-task component. The intervention will be implemented over an 8-week period, consisting of two sessions per week administered by a physiotherapist and one home-based session per week conducted by the family.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timed Up and Go Test (TUG)
Time Frame: It will be performed before the initiation of treatment and after the completion of the 8-week treatment period.

The Timed Up and Go Test is a simple, objective, and reliable method used to assess balance, postural control, and functional mobility. At the beginning of the test, the child sits on a chair without armrests, with the hips and knees flexed at 90 degrees. The child is then instructed to stand up from the chair, walk 3 meters at a comfortable pace, turn around in their preferred direction, walk back to the chair, and sit down. The timer starts when the child rises from the chair and stops when the child sits back down. Two trials are performed, and the best performance, expressed in seconds, is recorded.

It will be performed before the initiation of treatment and after the completion of the 8-week treatment period.
Four Square Step Test (FSST)
Time Frame: It will be performed before the initiation of treatment and after the completion of the 8-week treatment period.

The Four Square Step Test is used to assess dynamic balance and requires individuals to rapidly change direction while stepping in four different directions. Four canes, each 90 cm in length, are placed on a flat surface to form four squares. The squares are numbered with colored numbers positioned at the outermost corners to indicate the sequence of the test.At the beginning of the test, the child is instructed to stand in square 1, facing square 2. The child is then asked to step into the numbered squares in the following sequence: 2-3-4-1-4-3-2-1. The child is instructed to complete the sequence as quickly as possible without touching the canes and while ensuring that both feet make contact with the floor simultaneously within each square.Timing begins when the child steps into square 2 and stops when the child steps into square 1 at the end of the sequence. Two trials are performed, and the best performance is recorded in seconds.

It will be performed before the initiation of treatment and after the completion of the 8-week treatment period.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Two-Minute Walk Test (2MWT)
Time Frame: It will be performed before the initiation of treatment and after the completion of the 8-week treatment period.

The functional capacity of the children will be assessed using the Two-Minute Walk Test (2MWT). The distance walked by each child over a period of two minutes will be recorded.

It will be performed before the initiation of treatment and after the completion of the 8-week treatment period.
The Children's Assessment of Participation and Enjoyment (CAPE)
Time Frame: It will be performed before the initiation of treatment and after the completion of the 8-week treatment period.

The Children's Assessment of Participation and Enjoyment (CAPE) questionnaire assesses the participation patterns and activity preferences of children with and without disabilities across five categories: recreational, physical, social, skill-based, and self-improvement activities. It evaluates participation in terms of the diversity and frequency of activities, the settings in which they occur, the people with whom children participate, and their level of enjoyment.

It will be performed before the initiation of treatment and after the completion of the 8-week treatment period.
Stroop Test
Time Frame: It will be performed before the initiation of treatment and after the completion of the 8-week treatment period.

The Stroop Test Çapa Form will be used to assess attentional performance. This version of the Stroop Test, for which Turkish validity and reliability were established by Emek et al., consists of 60 colored rectangles (0.5 × 1 cm) in red, blue, and green, and 60 randomly ordered color words printed in incongruent colors (red, blue, and green).In the first stage, to assess reading fluency, participants will be asked to name the colors of the rectangles as quickly as possible, and the completion time will be recorded (Stroop A). In the second stage, participants will be asked to read the color words printed in incongruent ink colors (Stroop B). In the third stage, participants will be instructed not to read the words but to name only the ink colors in which the words are printed, and the completion time will be recorded (Stroop C).The difference in completion time between the third and second stages will be calculated as an indicator of resistance to interference, also referred to as r

It will be performed before the initiation of treatment and after the completion of the 8-week treatment period.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 3, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

February 1, 2027

Study Registration Dates

First Submitted

November 8, 2026

First Submitted That Met QC Criteria

November 8, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 8, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be made publicly available. De-identified data may be shared with qualified researchers upon reasonable request to the principal investigator, subject to ethics committee approval.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe